VJOncology is committed to improving our service to you

ESMO Breast 2020 | Targeting Low HER2 expression with antibody-drug conjugates

VJOncology is committed to improving our service to you

Giuseppe Curigliano

Giuseppe Curigliano, MD, PhD, University of Milano, Milan, Italy, discusses low HER2 expression metastatic breast cancer and its treatment with antibody-drug conjugates. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter